Medicare Enrolled
Dr. Timothy Lucas, MD
Pulmonary Disease · Altoona, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lucas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lucas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lucas
Dr. Timothy Lucas is a pulmonary disease specialist in Altoona, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lucas performed 2,759 Medicare services across 1,422 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lucas received a total of $40,292 from 57 pharmaceutical and/or device companies across 1208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lucas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in PA
$40,292 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,759
Medicare services
Top 4% in PA for pulmonary disease
1,422
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~138 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
892 | $62 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
517 | $88 | $175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
253 | $93 | $122 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
163 | $31 | $60 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
122 | $102 | $175 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
119 | $18 | $85 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
93 | $37 | $70 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
85 | $37 | $70 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
60 | $42 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $58 | $110 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
47 | $28 | $125 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
46 | $33 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $109 | $200 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
43 | $25 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
42 | $132 | $185 |
| New patient office visit, complex (60-74 min) | 32 | $153 | $250 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
25 | $2 | $15 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
24 | $14 | $25 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
24 | $24 | $25 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
23 | $39 | $50 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
22 | $76 | $100 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
18 | $478 | $1,100 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
11 | $71 | $270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$40,292
Total received (2018-2024)
Avg $5,756/year across 7 years
Top 9% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
1,208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,094 (52.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,197 (47.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,230
2023
$2,634
2022
$2,636
2021
$3,110
2020
$6,330
2019
$3,062
2018
$19,291
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$658
GlaxoSmithKline, LLC.
$614
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
Regeneron Healthcare Solutions, Inc.
$198
Actelion Pharmaceuticals US, Inc.
$170
Mallinckrodt Hospital Products Inc.
$137
JAZZ PHARMACEUTICALS INC.
$121
GENZYME CORPORATION
$113
Avadel CNS Pharmaceuticals, LLC
$112
Inspire Medical Systems, Inc.
$103
SANOFI-AVENTIS U.S. LLC
$90
United Therapeutics Corporation
$79
Takeda Pharmaceuticals U.S.A., Inc.
$75
Mylan Specialty L.P.
$66
Vifor Pharma, Inc.
$64
Merck Sharp & Dohme LLC
$49
Insmed, Inc.
$47
Axsome Therapeutics, Inc.
$43
Philips North America LLC
$40
Amgen Inc.
$36
Grifols USA, LLC
$33
Pulmonx Corporation
$31
Resmed Corp
$31
ANI Pharmaceuticals, Inc.
$27
HARMONY BIOSCIENCES LLC
$25
ABBVIE INC.
$19
Paratek Pharmaceuticals, Inc.
$15
Genentech USA, Inc.
$13
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$12,603
GlaxoSmithKline, LLC.
$6,847
Sunovion Pharmaceuticals Inc.
$5,477
AstraZeneca Pharmaceuticals LP
$3,928
Actelion Pharmaceuticals US, Inc.
$1,161
Regeneron Healthcare Solutions, Inc.
$830
GENZYME CORPORATION
$753
Grifols USA, LLC
$708
JAZZ PHARMACEUTICALS INC.
$701
Mylan Specialty L.P.
$628
Gilead Sciences, Inc.
$558
United Therapeutics Corporation
$516
PFIZER INC.
$445
Insmed, Inc.
$372
Mallinckrodt Hospital Products Inc.
$333
Genentech USA, Inc.
$319
Takeda Pharmaceuticals U.S.A., Inc.
$316
Electromed, Inc.
$288
SANOFI-AVENTIS U.S. LLC
$267
Harmony Biosciences LLC
$265
Shire North American Group Inc
$214
Novartis Pharmaceuticals Corporation
$214
Jazz Pharmaceuticals Inc.
$195
Philips Electronics North America Corporation
$194
Merck Sharp & Dohme LLC
$151
Advanced Respiratory, Inc
$148
Resmed Corp
$146
Circassia Pharmaceuticals Inc
$139
Inspire Medical Systems, Inc.
$121
Eisai Inc.
$119
Avadel CNS Pharmaceuticals, LLC
$112
Axsome Therapeutics, Inc.
$111
Teva Pharmaceuticals USA, Inc.
$100
Baxter Healthcare
$99
ZOLL Respicardia, Inc.
$81
HARMONY BIOSCIENCES LLC
$75
Vifor Pharma, Inc.
$64
Merck Sharp & Dohme Corporation
$57
Amgen Inc.
$55
Paratek Pharmaceuticals, Inc.
$54
IDORSIA PHARMACEUTICALS US INC
$48
Pulmonx Corporation
$46
ADVANCED RESPIRATORY, INC
$43
Philips North America LLC
$40
Allergan, Inc.
$40
Allergan Inc.
$39
ABBVIE INC.
$36
Vapotherm Inc
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
UCB, Inc.
$31
Optinose US, Inc.
$30
ANI Pharmaceuticals, Inc.
$27
AbbVie Inc.
$18
Melinta Therapeutics, Inc.
$17
Mallinckrodt LLC
$15
Alexion Pharmaceuticals, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRCURVE · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · APNEALINK · AREXVY · ASMANEX · AVYCAZ · Adempas · AirDuo Digihaler · AirSense · Arikayce · Astral · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FLUARIX · FLULAVAL · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · INSPIRE · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · Letairis · Life 2000 Ventilation System · NUCALA · NUZYRA · Neupro · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 13 · PURIFIED CORTROPHIN GEL · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Ultomiris · Utibron · VAPOTHERM · Vabomere · WAKIX · WINREVAIR · Wakix · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · Zemaira · myAir · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for pulmonary disease in PA.
Geographic Context
Pulmonary diseases within 10 mi
6
Per 100K population
4.9
County median income
$60,594
Nearest hospital
UPMC ALTOONA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lucas is a clinical cardiology specialist, with above-average Medicare volume (top 4% in PA), with speaking/promotional industry engagement in the top 9% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lucas experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Lucas performed 892 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lucas receive payments from pharmaceutical companies?
Yes. Dr. Lucas received a total of $40,292 from 57 companies across 1,208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lucas's costs compare to other pulmonary diseases in Altoona?
Dr. Lucas's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lucas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Altoona
Browse pulmonary diseases in Altoona ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology